Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Ribociclib
Related studies linked through entity extraction aliases.
Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase I/II Study of Ribociclib,a CDK4/6 Inhibitor, Following Radiation Therapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma
- Status
- UNKNOWN
- Phase
- PHASE2
Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE3
Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin
- Status
- COMPLETED
- Phase
- PHASE2
Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors or Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Glioma
- Status
- UNKNOWN
- Phase
- PHASE1
Detect V / CHEVENDO (Chemo vs. Endo)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer.
- Status
- COMPLETED
- Phase
- PHASE1
Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs).
- Status
- COMPLETED
- Phase
- PHASE2
Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3